" /> Pexidartinib Hydrochloride - CISMeF





Preferred Label : Pexidartinib Hydrochloride;

NCIt synonyms : Pexidartinib Monohydrochloride; 5[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)pyridin-3yl]methyl}pyridin-2-amine Monohydrochloride; (5-(5-Chloro-1H-pyrrolo(2,3-b)pyridin-3-ylmethyl)-pyridin-2-yl)-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine Hydrochloride Salt; PLX3397 Hydrochloride;

NCIt definition : The hydrochloride salt form of pexidartinib, a small-molecule receptor tyrosine kinase (RTK) inhibitor of proto-oncogene receptor tyrosine kinase (KIT), colony-stimulating factor-1 receptor (CSF1R) and FMS-like tyrosine kinase 3 (FLT3), with antineoplastic activity. Upon oral administration, pexidartinib targets, binds to and inhibits phosphorylation of KIT, CSF1R and FLT3 harboring an internal tandem duplication (ITD) mutation. This results in the inhibition of tumor cell proliferation. FLT3, CSF1R and FLT3 are overexpressed or mutated in many cancer cell types and play major roles in tumor cell proliferation and metastasis.;

UNII : YS6WAI3XN7;

InChIKey : CJLUYLRKLUYCEK-UHFFFAOYSA-N;

CAS number : 2040295-03-0;

Drug name : Turalio;

Molecule name : FP-113;

NCI Metathesaurus CUI : CL1382556;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.